Robert F Doman - Net Worth and Insider Trading
Robert F Doman Net Worth
The estimated net worth of Robert F Doman is at least $6 Million dollars as of 2024-11-13. Robert F Doman is the President and CEO, Director of Davis Select U.S. Equity ETF and owns about 130,000 shares of Davis Select U.S. Equity ETF (DUSA) stock worth over $6 Million. Details can be seen in Robert F Doman's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Robert F Doman has not made any transactions after 2008-08-22 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Robert F Doman
Robert F Doman Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Robert F Doman owns 2 companies in total, including Akari Therapeutics PLC (AKTX) , and Echo Therapeutics Inc (ECTE) .
Click here to see the complete history of Robert F Doman’s form 4 insider trades.
Insider Ownership Summary of Robert F Doman
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| AKTX | Akari Therapeutics PLC | 2015-01-01 | director |
| ECTE | Echo Therapeutics Inc | 2013-10-01 | director & EXEC. CHAIRMAN AND INTERIM CEO |
Robert F Doman Latest Holdings Summary
Robert F Doman currently owns a total of 1 stock. Robert F Doman owns 130,000 shares of Davis Select U.S. Equity ETF (DUSA) as of August 22, 2008, with a value of $6 Million.
Latest Holdings of Robert F Doman
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| DUSA | Davis Select U.S. Equity ETF | 2008-08-22 | 130,000 | 44.01 | 5,721,300 |
Holding Weightings of Robert F Doman
Robert F Doman Form 4 Trading Tracker
According to the SEC Form 4 filings, Robert F Doman has made a total of 0 transactions in Davis Select U.S. Equity ETF (DUSA) over the past 5 years. The most-recent trade in Davis Select U.S. Equity ETF is the acquisition of 5,000 shares on August 22, 2008, which cost Robert F Doman around $8,650.
Insider Trading History of Robert F Doman
- 1
Robert F Doman Trading Performance
Robert F Doman Ownership Network
Ownership Network List of Robert F Doman
Ownership Network Relation of Robert F Doman
Robert F Doman Owned Company Details
What does Akari Therapeutics PLC do?
Who are the key executives at Akari Therapeutics PLC?
Robert F Doman is the director of Akari Therapeutics PLC. Other key executives at Akari Therapeutics PLC include General Counsel and Secretary Robert M Shaw , director & 10 percent owner James Hill , and director & 10 percent owner Stuart Ungar .
Akari Therapeutics PLC (AKTX) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Akari Therapeutics PLC (AKTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Akari Therapeutics PLC (AKTX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Akari Therapeutics PLC (AKTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Akari Therapeutics PLC Insider Transactions
Robert F Doman Mailing Address
Above is the net worth, insider trading, and ownership report for Robert F Doman. You might contact Robert F Doman via mailing address: C/o Dusa Pharmaceuticals, Inc., 25 Upton Drive, Wilmington Ma 01887.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
